Search Results (163)

Background/Objectives: An incorrect intradeltoid injection technique can cause shoulder injury related to vaccine administration, including bursitis, septic arthritis, and axillary nerve injury, particularly when Western-derived landmarks and needle-length tables are applied to smaller-framed Southeast Asian adults. We aimed to define an individualized deltoid injection landmark and needle length that avoid the axillary nerve while ensuring reliable intramuscular delivery in Southeast Asian adults. Methods: In this cross-sectional ultrasound study of adults aged ≥18 years, four vertical landmarks below the acromion (individual contralateral 2-fingerbreadth (FB), individual contralateral 3-FB, average 2-FB, average 3-FB) were assessed in two arm positions (adduction and approximately 30° abduction with the hand on the waist). For each combination, we recorded the presence of the axillary nerve and measured skin-to-subcutaneous and deltoid muscle thickness to estimate whether 0.5-, 1-, or 1.5-inch needles would terminate within muscle or penetrate the subdeltoid bursa. Results: Eighty-two participants (39 males, 43 females) were included. The axillary nerve was not visualized at the individualized contralateral 2-FB landmark in adduction but was present at 31.7–50.0% of other landmark–position combinations. At the individualized 2-FB site in adduction, mean skin-to-subcutaneous thickness was <12.7 mm and mean skin-to-subdeltoid fascia distance exceeded 12.7 mm in all strata, implying that a 0.5-inch needle would consistently terminate within the deltoid muscle. Conclusions: In Southeast Asian adults, the contralateral individualized 2-FB landmark in arm adduction provides a neurovascularly safe window for intradeltoid vaccination, and a 0.5-inch needle offers reliable intramuscular delivery while minimizing the risk of bursal penetration. Full article

Background: Total hip arthroplasty (THA) for the late sequelae of childhood septic hip arthritis is technically demanding, and infection-related risk remains incompletely defined. This systematic review and meta-analysis address the research question: “In adults undergoing THA after childhood septic arthritis of the hip, what is the incidence of post-THA infection, revision, and mechanical/neurologic complications?” We systematically reviewed and meta-analyzed outcomes after THA in patients with septic hip arthritis diagnosed at ≤18 years. Methods: PubMed, Web of Science, Scopus, and the Cochrane Library were searched from inception to 31 December 2025 (PRISMA). Eligible studies reported THA outcomes after childhood septic arthritis and met a Methodological Index for Non-Randomized Studies (MINORS) threshold (≥9). A random-effects meta-analysis of events per hip was performed. Results: Nine studies were included; eight contributed to the quantitative synthesis (343 hips). The pooled incidence of any post-THA infection was 1.55% (95% CI 0.38–3.48; I² = 23.8%; 5/343); when microbiology was available, no relapse due to the index organism was reported and events were classified as new infections. The pooled incidence of revision for any cause was 4.99% (95% CI 2.27–8.70; I² = 43.4%; 15/334). Non-infectious complications were clinically relevant, including intraoperative fracture (6.95%) and nerve palsy (4.84%). Evidence was limited by retrospective designs and heterogeneous reporting. Conclusions: THA after childhood septic hip arthritis demonstrates a low risk of postoperative infection, with relapse of the original pathogen appearing rare in carefully selected quiescent cases, but a clinically meaningful burden of mechanical and neurologic complications. These findings underscore the importance of careful preoperative assessment, meticulous surgical technique, and highlight the limitations of the current evidence. The protocol was registered in PROSPERO (ID: CRD420261298181). No external funding was received. Full article

Background/Objectives: Non-typhoidal Salmonella (NTS) species are well-recognized causes of invasive infection in patients with sickle cell disease (SCD), with a particular predilection for the musculoskeletal system. Although Salmonella osteomyelitis is well described in this population, septic arthritis is uncommon, especially involving the shoulder joint. We describe a case of NTS bacteremia complicated by native shoulder septic arthritis in a patient with SCD and review its clinical implications. Methods: We report the clinical course, diagnostic evaluation, microbiologic findings, imaging studies, and management of a 22-year-old man with homozygous SCD who presented with a vaso-occlusive pain crisis and subsequently developed severe sepsis with persistent Salmonella enterica bacteremia following ingestion of undercooked poultry. Persistent bacteremia prompted further evaluation for metastatic infection using advanced imaging and diagnostic arthrocentesis. Results: Whole-body imaging identified septic arthritis of the native right shoulder, which was confirmed by synovial fluid cultures growing Salmonella species. The patient underwent arthroscopic irrigation and debridement for source control. Antimicrobial therapy was narrowed to intravenous ceftriaxone based on susceptibility data and continued for six weeks. The patient demonstrated clinical improvement with resolution of bacteremia and was discharged to rehabilitation to complete therapy. Conclusions: This case highlights the importance of a careful exposure history, including foodborne sources, in patients with SCD presenting with invasive Salmonella infection. Persistent bacteremia should prompt early investigation for metastatic foci, and timely surgical source control combined with targeted antimicrobial therapy is essential for optimal outcomes in this population. Full article

Background: Neonatal septic arthritis is a rare but potentially devastating infection that can present with subtle clinical signs and rapidly progress to joint destruction, osteomyelitis, and permanent sequelae. We aimed to describe the clinical and microbiological characteristics, imaging findings, management, and follow-up outcomes of neonatal septic arthritis patients and to report ultrasonography (US) and magnetic resonance imaging (MRI) findings within the same cohort. Methods: This retrospective observational study was conducted in a tertiary neonatal intensive care unit and included neonates who were diagnosed with septic arthritis between January 2016 and December 2025. Demographic, clinical, laboratory, microbiological, imaging, treatment, and outcome data were systematically obtained from medical records. The diagnosis was based on compatible clinical findings supported by laboratory and/or microbiological evidence, with imaging used to support diagnosis and guide management. Results: Twelve neonates were included. The median gestational age was 36.5 weeks (26–40), and the median birth weight was 2435 g. The median symptom onset was 22 days of life. The hip (n = 4) and knee (n = 4) were most commonly affected. Pseudoparalysis and swelling were the most frequent findings. Synovial cultures were positive in 10/12 (Staphylococcus aureus, n = 7; methicillin-resistant Staphylococcus aureus (MRSA), n = 3), and blood cultures were positive in 6/12. US detected joint effusion in 33% of the patients, whereas MRI revealed inflammatory changes in all the patients. Concomitant osteomyelitis occurred in 5/12 patients. Orthopedic sequelae developed in 6/12; no mortality was observed. Conclusions: Neonatal septic arthritis is associated with a substantial risk of osteomyelitis and early sequelae. Delayed recognition may worsen outcomes. Normal ultrasonographic findings should not exclude the diagnosis when clinical suspicion persists, and MRI may provide complementary information for timely management. Full article

Well-designed randomized controlled trials (RCTs) have demonstrated safe and effective use of oral antimicrobial therapy for bone and joint infections. Application of data for implementation into real-world practice, however, has inherent challenges. This retrospective cohort study compared real-world use of intravenous versus oral antimicrobial therapy in bone and joint infections within a large healthcare system comprising both academic and community medical centers. The primary outcome was the proportion of treatment failure. Key secondary outcomes included the proportion of patients with logistical failure and risk factors associated with treatment and logistical failure. Among 166 patients included, 136 (82%) and 30 (18%) received predominantly intravenous and oral antimicrobial therapy, respectively. Treatment failure occurred in (77/121) 64% versus (18/25) 72% of patients in the intravenous and oral antimicrobial groups (p = 0.491; OR, 1.38; 95% CI, 0.56–3.33). Logistical failure occurred in 29% versus 47% of patients in the intravenous and oral antimicrobial groups (p = 0.150; OR, 1.93; 95% CI 0.79–4.70). Risk factors for treatment failure included peripheral vascular disease (OR, 2.61; 95% CI 1.02–7.80) and higher Charlson Comorbidity Index scores (OR, 1.18; 95% CI 1.04–1.36). Similar to previously published RCTs, treatment failure appeared comparable between groups; however, oral antimicrobial therapy was overall underutilized. Full article

Background/Objectives: Streptococcus intermedius, a member of the Streptococcus anginosus group, is characterized by a marked propensity for abscess formation but only rarely causes native-joint septic arthritis. Involvement of the acromioclavicular (AC) joint is particularly uncommon. We describe a case of native AC joint septic arthritis due to S. intermedius in a patient with multiple predisposing factors and highlight diagnostic and management considerations. Methods: We report the clinical course of a 72-year-old man with poorly controlled type 2 diabetes mellitus who presented with progressive right shoulder pain, erythema, and swelling following recurrent minor skin abrasions from a newly adopted dog. Initial management for presumed inflammatory shoulder pathology included brief systemic corticosteroids and an ultrasound-guided intra-articular ketorolac injection. Magnetic resonance imaging (MRI) was performed after symptom progression. The patient underwent operative irrigation and debridement with collection of synovial fluid and deep tissue cultures. Blood cultures and transthoracic echocardiography were obtained to evaluate for systemic involvement. Results: MRI demonstrated multiloculated periarticular abscesses and osteolysis centered on the AC joint. Operative cultures yielded high colony counts of S. intermedius from synovial fluid and deep tissues. Blood cultures and echocardiography were negative. The patient required multiple operative debridements with irrigation, adjunctive local antibiotic therapy, and prolonged targeted β-lactam treatment. Clinical and radiographic improvement was achieved following surgical source control and antimicrobial therapy. Conclusions: Native AC joint septic arthritis due to S. intermedius is rare. Older age, uncontrolled diabetes, recent intra-articular intervention, and possible zoonotic inoculation from canine wound licking may represent contributory risk factors. Early imaging, prompt surgical source control, and guideline-concordant antimicrobial therapy are essential when bone and soft tissue involvement is present. Full article

Background: Bone and joint infections (BJIs), including osteomyelitis, septic arthritis, and periprosthetic joint infections, typically require prolonged antimicrobial therapy and often involve complex outpatient management. Oritavancin, a long-acting lipoglycopeptide approved for the treatment of acute bacterial skin and skin structure infections caused by Gram-positive bacteria, has emerged as a potential off-label option for BJIs owing to its favourable pharmacokinetic and pharmacodynamic properties. Objectives: To provide a comprehensive overview of the pharmacological rationale, microbiological activity, and available clinical evidence supporting the use of oritavancin in BJIs. Methods: A comprehensive narrative review of the literature was performed using MEDLINE and the Cochrane Central Register of Controlled Trials (CENTRAL), focusing on publications from 2011 to 2025. Observational studies, case series, and case reports describing the off-label use of oritavancin in BJIs were considered. Results: The available literature primarily consists of observational studies and real-world experiences. Eighteen studies met the inclusion criteria. Oritavancin was most frequently evaluated for osteomyelitis (n = 14 studies), prosthetic joint infections (n = 10) and septic arthritis (n = 5). Multi-dose regimens, typically including a 1200 mg loading dose followed by weekly doses of 800–1200 mg, were the most commonly described strategies. Reported clinical success rates generally ranged from approximately 70% to over 90%. Oritavancin was overall well tolerated, with adverse events being mostly mild and self-limiting. Conclusions: Current evidence suggests that oritavancin may represent an effective and well-tolerated off-label option for selected patients with Gram-positive BJIs. Its use may offer practical advantages, including reduced hospitalization and avoidance of prolonged intravenous antimicrobial therapy, particularly in patients for whom standard treatment approaches are challenging. Full article

Invasive meningococcal disease (IMD) is classically associated with meningitis and septic shock, but an increasing proportion of cases present with atypical, extra-meningeal manifestations. Following the COVID-19 pandemic, major epidemiological shifts have occurred in France, including a rebound in IMD incidence and changes in circulating serogroups and clonal complexes. We conducted a nationwide retrospective study including all laboratory-confirmed IMD cases analysed by the French National Reference Centre between July 2014 and June 2025. Clinical presentations were coded as non-exclusive entities. Associations with age, serogroup, clonal complex, antimicrobial susceptibility and early mortality (≤72 h) were assessed using descriptive analyses and multivariable logistic regression models. Among 4328 IMD cases, sepsis/shock (61.1%) and meningeal involvement (54.9%) predominated, while atypical forms were frequent, including bacteraemic pneumonia (7.7%), abdominal presentations (8.0%) and arthritis (6.0%). Bacteraemic pneumonia was strongly associated with older age and serogroups W and Y, whereas abdominal forms predominated in adolescents and young adults and were independently associated with serogroups W and Y and clonal complex (cc) cc11. Abdominal presentations were independently associated with early mortality (adjusted odds ratio [aOR] 2.40) but not meningococcal pneumonia. Abdominal presentations were associated with serogroup W (aOR 2.27; 95% CI 1.35–3.83) and serogroup Y (aOR 2.92; 95% CI 1.79–4.75) and with cc11 (aOR 1.77; 95% CI 1.07–2.94). In contrast, cc23 was associated with lower odds of abdominal involvement (aOR 0.42; 95% CI 0.25–0.70). Overall, atypical presentations now represent a substantial proportion of IMD in France and are strongly shaped by age and meningococcal lineage. These findings highlight diagnostic challenges, prognostic heterogeneity and the need for continued integrated clinical, microbiological and genomic surveillance in the context of evolving vaccination strategies. Full article

Management of septic arthritis of the pubic symphysis (SAS) presents with substantial clinical challenges. Firstly, the SAS is an extremely rare entity. Surgical resection of the symphysis plus targeted antibiotic therapy is a widely adopted treatment course. Some patients suffering from SAS develop posterior pelvic insufficiency fractures because of the weakened anterior pelvic ring or as a result of radiation therapy received during treatment for a malignant disease in the lesser pelvis. The literature demonstrates a lack of standardized strategies for restoring pelvic ring integrity based on pelvic instability and posterior pelvic insufficiency fractures caused by SAS. Background and Objectives: This study aimed to determine whether early, primary stand-alone dorsal fusion can be a viable treatment option in SAS and whether there is a clinical benefit compared with temporary anterior fixation or secondary posterior stabilization after failed anterior fixation. Materials and Methods: We performed a descriptive, retrospective analysis covering an eight-year period (2018–2025) including 21 patients who underwent symphyseal resection for destructive SAS. We evaluated peri- and postsurgical data to describe the different surgical methods and their respective outcomes. Results: Ten patients (10/21, 48%) received posterior stabilization (sacroiliac-joint fusion or spinopelvic stabilization). Seven patients (7/21, 33%) were anteriorly fixated either temporarily with an external fixator or permanently with ventral plate osteosynthesis. Four patients (4/21, 19%) did not receive any pelvic stabilization following symphyseal resection as pelvic integrity was present. Three of them (3/21, 14%) showed spontaneous sacroiliac-joint fusion, while 6/7 (86%) of anteriorly fixed patients presented with debilitating sacral insufficiency fractures, had longer hospital stays and a higher count of readmissions and re-operations. Primary posterior stabilization led to shorter hospital stays, less readmissions, and good clinical outcome. Conclusions: Primary posterior stabilization can be a viable course of treatment of SAS and should be considered especially when spontaneous sacroiliac-joint fusion is not present. We suggest that early stabilization of the posterior pelvic ring could be a sensible course of treatment and may prevent debilitating insufficient fractures. While there are many different surgical options for posterior stabilization available (spinopelvic/lumbosacral stabilization, sacroiliac-joint fusion and others), our preliminary data suggest that primary sacroiliac-joint fusion is a quick, minimally invasive and effective way to establish posterior pelvic stability. Full article

Background/Objectives: Septic arthritis of native joints is an orthopedic emergency in which rapid discrimination from non-infectious arthritis is crucial. Because cartilage damage can occur within hours, urgent irrigation and debridement are often pursued on an emergency basis (ideally within the first 6–8 h) of presentation, underscoring the need for rapidly available biomarkers. The delta neutrophil index (DNI) quantifies circulating immature granulocytes and may complement conventional inflammatory biomarkers such as C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), white blood cell count (WBC), and procalcitonin (PCT). We evaluated the diagnostic performance of DNI for native-joint septic arthritis against both microbiologic and clinical reference standards. Methods: We retrospectively analyzed 85 adults who underwent surgical irrigation and debridement for suspected native joint septic arthritis at a tertiary center. Serum CRP, ESR, WBC, DNI, and PCT (available in 67 patients) were recorded together with synovial leukocyte counts. Infection status was defined using either positive synovial culture (microbiologic reference) or clinical adjudication according to the Guideline for management of septic arthritis in native joints (SANJO). Diagnostic performance was assessed using receiver operating characteristic (ROC) curves and the area under the ROC curve (AUC); exploratory cut-offs were identified by the Youden index, and pairwise AUCs were compared using DeLong’s test. Results: Synovial leukocyte analysis was highly sensitive but poorly specific (sensitivity 92.9%, specificity 10.3%). Against culture, DNI showed the highest discrimination (AUC = 0.914), exceeding CRP (0.687), ESR (0.643), WBC (0.648), and PCT (0.697); DeLong ΔAUC vs. CRP 0.227 (p < 0.001), ESR 0.270 (p < 0.001), WBC 0.266 (p < 0.001), PCT 0.227 (p = 0.001). At pre-specified cut-offs, DNI showed the most balanced sensitivity/specificity (94.3%/84.0%), corresponding to a negative predictive value (NPV) of 95.5% (42/44) and a positive predictive value (PPV) of 80.5% (33/41) against culture in this cohort. Against clinical infection, DNI outperformed others (AUC:0.921; ΔAUC vs. CRP = 0.204, ESR = 0.343, WBC = 0.244, PCT = 0.295; all p < 0.001). As a rule-in threshold, DNI ≥ 0.6 yielded a specificity of 100% with a sensitivity of 73.2%. In culture-negative patients (infected n = 21, uninfected n = 29), DNI remained discriminatory (AUC 0.80, p < 0.001), whereas other biomarkers were not. Conclusions: DNI demonstrated superior diagnostic accuracy compared with conventional inflammatory biomarkers. As a rapid parameter available with the initial complete blood count, DNI may support early risk stratification and rule-in decisions within the first hours of presentation; however, it should be used as a supplementary indicator alongside synovial fluid analysis and clinical assessment rather than as a stand-alone diagnostic tool. Full article

Background/Objectives: Septic temporomandibular joint disease (STMJ) is a rare condition with a potentially dangerous course. Its etiology includes bacterial and fungal infections, systemic factors (e.g., diabetes, immunodeficiencies), and molecular mechanisms. Methods: Reports of SATMJ in adults, clinically and microbiologically confirmed, published up to the time of protocol registration (PROSPERO CRD42024613462), were included. ACM, BASE, CENTRAL, PubMed, ClinicalTrials.gov, Embase, Scopus, Google Scholar, and reference lists were searched. The search included strategies using the terms “temporomandibular joint septic arthritis” and related phrases. Two independent reviewers studied a selection of articles and extracted data (demographics, microbiology, risk factors, molecular mechanisms). Risk of bias was assessed using JBI tools, and the certainty of evidence was assessed using the GRADE tool. Results: The analysis included 59 cases of SATMJ. Anaerobic infections were found in 77%, Gram-positive infections in 72%, and fungal infections in only 7%. Diabetes and immunoincompetence were associated with SATMJ. Conclusions: The results highlight the predominance of Gram-positive and anaerobic infections. Systemic factors, such as diabetes, increase the risk of SATMJ. Limitations result from the heterogeneity and retrospective nature of the analyzed cases and possible publication biases. Full article

Central nervous system (CNS) infections caused by Salmonella species (spp.) are exceptionally rare in adults but are associated with significant morbidity and mortality, particularly in immunocompromised individuals. Clinical presentation is often nonspecific, including fever, headache, or altered mental status, while imaging may demonstrate meningeal enhancement, abscesses, or cytotoxic lesions. We present a systematic review of non-typhoidal Salmonella spp. infections involving the CNS across various immunosuppressive contexts, illustrated by the case of a 38-year-old HIV-positive man with well-controlled infection. He developed disseminated Salmonella enterica infection, with bacteremia, septic arthritis, and ultimately corpus callosum involvement, following chronic self-administration of corticosteroids for cluster headaches. This case underscores that corticosteroid exposure can precipitate systemic dissemination even in patients with preserved CD4 counts. Although this condition carries a high risk of mortality, early recognition, targeted antibiotic therapy, and careful multidisciplinary management of underlying immunosuppression are critical to improving survival and minimizing neurological sequelae. Full article

Background: Septic arthritis of the hip (SAH) requires emergent surgical intervention. While open arthrotomy has been the traditional approach, arthroscopic treatment is emerging as an effective alternative. Tractionless techniques in adult populations remain understudied. Methods: Twenty-one patients (22 hips) met inclusion criteria. Six patients (7 hips) were excluded for age < 18 years, post-COVID osteomyelitis, prior hip surgery, or insufficient records, resulting in a final cohort of 15 patients. All fifteen patients underwent tractionless arthroscopic irrigation and debridement for suspected SAH (2014–2023). Inclusion required ≥2 clinical criteria (hip pain, limited range of motion, inability to bear weight, fever > 38 °C) AND ≥ 1 laboratory criterion (leukocytosis, elevated CRP, synovial WBC > 50,000, positive culture). Primary outcomes included Visual Analog Scale pain scores, inflammatory markers, and complications. Results: Median age was 33 years (range 20–76); 60% were female. VAS scores improved from 7 (6–10) to 1 (0–3) at discharge (p < 0.001). CRP levels decreased from 115 mg/L (35–206) to <5 mg/L (<5–9) postoperatively (p < 0.001). Positive cultures were obtained in 26.7% of cases, predominantly methicillin-sensitive Staphylococcus aureus. No perioperative complications occurred. Histopathological analysis revealed tenosynovial giant cell tumor (TGCT) in 33.3% of cases, representing an important differential diagnosis. Among non-TGCT cases, the culture-positive rate was 40%. No infection recurrence was observed during a minimum one-year follow-up. Conclusions: Tractionless arthroscopic irrigation and debridement appears effective for managing suspected SAH in adults, achieving significant improvements in pain scores and inflammatory markers without perioperative complications. This technique offers potential advantages by eliminating traction-related risks while maintaining effective joint debridement. Additionally, TGCT should be considered in the differential diagnosis of suspected SAH with culture-negative inflammatory arthropathy. Full article

Total joint arthroplasty is among the most common surgical procedures performed worldwide, with frequency increasing due to demographic changes. Accelerating the diagnostic process using new techniques is crucial for effective therapy. This pilot study aims to test such innovative technology in the context of periprosthetic joint infection (PJI) using Scattered Light Integrating Collector (SLIC) technology. While we wish to evaluate whether SLIC can be used to reliably detect the status of infection within human tissue samples in the future, our current research focused on building its foundation by evaluating steps of sample preparation that allow for heightened growth depiction. It is, to our knowledge, the first study concerning the usage of solid human tissue samples using the SLIC device. Adult patients presenting with native or periprosthetic joint infections were included in this prospective study. Biopsies were obtained using sequential sampling, and bacterial density was optimized through titration series. Cryopreservation and agents influencing coagulation were investigated. Our study demonstrates that simple pretreatment could aid in detecting pathogen growth in infected tissue samples. Findings showed a clear advantage for no addition of agents affecting coagulation. Additionally, our protocols proved reliable after prolonged cryopreservation at −20 °C for up to 8 weeks, showing no significant difference compared to primary testing. AUC comparison showed comparable results for sample storage at −80 °C for up to 8 weeks. Similar outcomes were seen for samples ranging from 25 µL to 300 µL, with biological replicates displaying higher thresholds for larger volumes without significant differences. This study introduces a simple and quick diagnostic tool for detecting bacterial growth using tissue biopsies and develops an SOP for further research with this innovative technique. The suggested SOP enables SLIC to hint at an underlying bacterial infection within 5 h using joint tissue, offering a possible novel approach in diagnosing periprosthetic joint infections and septic arthritis. While not yet designed to compare sensitivity to other culture methods, it provides a solid basis for further clinical research. Full article

Osteoarticular infections (OAIs), including osteomyelitis, septic arthritis, prosthetic joint infections, and facture-related infections, remain a major challenge due to biofilm formation and the prevalence of multidrug-resistant (MDR) pathogens. Although OAIs are predominantly caused by Staphylococcus aureus and coagulase-negative staphylococci, the increasing incidence of MDR Gram-negative infections adds further complexity to their management. Standard approaches, combining surgery and prolonged antibiotic therapy, frequently result in recurrence and poor outcomes. Bacteriophage (phage) therapy has emerged as a promising adjunct or alternative approach, offering high host specificity, replication at the infection site, and activity against biofilm-embedded bacteria. This review highlights recent advances in phage therapy for OAIs, focusing on administration routes (intravenous, intra-articular, topical, and oral) and on novel pharmaceutical delivery systems such as hydrogels, bone cements, microparticles, nanoparticles, and implant coatings. Preclinical and early clinical studies have analyzed phage stability, controlled release, and the synergistic effects of combined phage/antibiotic therapy. However, challenges remain regarding standardization, immunogenicity, and regulatory approval. Nonetheless, phage therapy shows promise for clinical translation as an adjunct or alternative to conventional treatments for OAIs. Well-designed clinical trials are urgently needed to confirm the efficacy of phage therapy, optimize delivery strategies, and integrate the treatments in routine practice. Despite encouraging outcomes for a successful clinical implementation, regulation and standardization of GMP production are required. Full article